INJECTION SITE CALCIFICATION

This adverse event was reported 125 times

INJECTION SITE CALCIFICATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE 1 0.0011
1 CHLOROTHIAZIDE SODIUM 1 0.0011
2 INTERFERON BETA-1B 15 0.0008
3 TESAMORELIN 1 0.0006
4 ASFOTASE ALFA 6 0.0006
5 CABOTEGRAVIR AND RILPIVIRINE 3 0.0005
6 TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% 9 0.0004
7 CALCITONIN SALMON 1 0.0003
8 TRIAMCINOLONE ACETONIDE 9 0.0003
9 CABERGOLINE 1 0.0002
See all drugs enriched for association with INJECTION SITE CALCIFICATION

INJECTION SITE CALCIFICATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tissue-nonspecific Alkaline Phosphatase [EPC] 6 0.0006
1 Calcitonin [EPC] 1 0.0003
2 Ergot Derivative [EPC] 1 0.0002
3 Interferon beta [EPC] 30 0.0002
4 Phenylalanine Metabolizing Enzyme [EPC] 1 0.0001
5 Provitamin D2 Compound [EPC] 3 0.0001
6 Insulin [EPC] 3 0.0001
7 Potassium Channel Blocker [EPC] 3 0.0000
8 Anti-IgE [EPC] 3 0.0000
9 Sympathomimetic-like Agent [EPC] 1 0.0000
See all drug classes enriched for association with INJECTION SITE CALCIFICATION